Literature DB >> 19543912

Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility.

Véronique Hofman1, Sandra Lassalle, Christelle Bonnetaud, Catherine Butori, Céline Loubatier, Marius Ilie, Olivier Bordone, Patrick Brest, Nicolas Guevara, José Santini, Brigitte Franc, Paul Hofman.   

Abstract

The term thyroid tumours of uncertain malignant potential (TT-UMP) has been proposed for a subgroup of follicular-patterned thyroid tumours for which benignancy or malignancy cannot be assessed with certainty. The frequency, diagnostic reproducibility, immunohistochemistry and molecular genetic profiling of such tumours have been poorly explored. We, therefore, investigated (1) the frequency of TT-UMP diagnosed in a single institution (Nice, France: 2004-2008), (2) the observer variation among four pathologists, (3) whether immunohistochemical and molecular genetic profiling of TT-UMP provide additional information concerning such lesions. A series of 31 diagnosed TT-UMP (2.9%) out of 1,078 consecutive thyroidectomies were analysed. It comprised 15 follicular thyroid tumours of UMP (FT-UMP) and 16 well-differentiated tumours of UMP (WDT-UMP). Observer concordance was 70% for all TT-UMP. More than 50% of FT-UMP expressed galectin-3 and CK19, whereas more than 50% of WDT-UMP expressed HBME-1. Five cases of TT-UMP showed N-RAS mutations, while one showed H-RAS mutation and another PAX8/PPARgamma rearrangement. In conclusion, the frequency of TT-UMP is low in our institution. Diagnostic reproducibility is within the same range as other published data on follicular-patterned thyroid tumours. The ancillary methods have a low impact on aiding diagnosis of such lesions.

Entities:  

Mesh:

Year:  2009        PMID: 19543912     DOI: 10.1007/s00428-009-0798-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  52 in total

1.  Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma.

Authors:  John K C Chan
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

2.  Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma.

Authors:  Brigitte Franc; Pauline de la Salmonière; Françoise Lange; Catherine Hoang; Albert Louvel; Anne de Roquancourt; Françoise Vildé; Gilles Hejblum; Sylvie Chevret; Claude Chastang
Journal:  Hum Pathol       Date:  2003-11       Impact factor: 3.466

3.  HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.

Authors:  Yasuhiro Ito; Hiroshi Yoshida; Chisato Tomoda; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kennichi Kakudo; Kanji Kuma; Akira Miyauchi
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

4.  [HBME-1 immunostaining in thyroid pathology].

Authors:  V Rigau; B Martel; C Evrard; P Rousselot; F Galateau-Salle
Journal:  Ann Pathol       Date:  2001-02       Impact factor: 0.407

5.  Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.

Authors:  M Miettinen; P Kärkkäinen
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

6.  Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.

Authors:  Zhaowen Zhu; Manoj Gandhi; Marina N Nikiforova; Andrew H Fischer; Yuri E Nikiforov
Journal:  Am J Clin Pathol       Date:  2003-07       Impact factor: 2.493

7.  Discrimination of benign and malignant thyroid nodules by molecular profiling.

Authors:  David J Finley; Baixin Zhu; Catherine B Barden; Thomas J Fahey
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

8.  Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivity.

Authors:  Liborio Torregrossa; Pinuccia Faviana; Tiziano Camacci; Gabriele Materazzi; Piero Berti; Michele Minuto; Rossella Elisei; Paolo Vitti; Paolo Miccoli; Fulvio Basolo
Journal:  Hum Pathol       Date:  2007-06-26       Impact factor: 3.466

9.  Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

Authors:  Armando Bartolazzi; Fabio Orlandi; Enrico Saggiorato; Marco Volante; Federico Arecco; Ruth Rossetto; Nicola Palestini; Ezio Ghigo; Mauro Papotti; Gianni Bussolati; Marco Paolo Martegani; Federico Pantellini; Angelo Carpi; Maria Rosaria Giovagnoli; Salvatore Monti; Vincenzo Toscano; Salvatore Sciacchitano; Gian Maria Pennelli; Caterina Mian; Maria Rosa Pelizzo; Massimo Rugge; Giancarlo Troncone; Lucio Palombini; Gennaro Chiappetta; Gerardo Botti; Aldo Vecchione; Rino Bellocco
Journal:  Lancet Oncol       Date:  2008-05-19       Impact factor: 41.316

10.  HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm.

Authors:  Takahiro Mase; Hiroomi Funahashi; Takashi Koshikawa; Tsuneo Imai; Yoshiharu Nara; Yuji Tanaka; Akimasa Nakao
Journal:  Endocr J       Date:  2003-04       Impact factor: 2.349

View more
  9 in total

1.  [Benign thyroid nodule or thyroid cancer?].

Authors:  D Führer; K W Schmid
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

2.  Cytopathological review of patients that underwent thyroidectomies based on the diagnosis of papillary thyroid carcinoma by fine needle aspiration cytology but were later found to have benign tumors by histopathology.

Authors:  Mutsukazu Kitano; Iwao Sugitani; Kazuhisa Toda; Motoko Ikenaga; Noriko Motoi; Noriko Yamamoto; Muneki Hotomi; Yoshihide Fujimoto; Kazuyoshi Kawabata
Journal:  Surg Today       Date:  2012-10-18       Impact factor: 2.549

Review 3.  [Molecular pathology of thyroid tumors].

Authors:  K W Schmid
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 4.  Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Authors:  Zubair W Baloch; Sylvia L Asa; Justine A Barletta; Ronald A Ghossein; C Christofer Juhlin; Chan Kwon Jung; Virginia A LiVolsi; Mauro G Papotti; Manuel Sobrinho-Simões; Giovanni Tallini; Ozgur Mete
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 3.943

5.  Comparing Clinicopathologic and Radiographic Findings Between TT-UMP, Classical, and Non-Encapsulated Follicular Variants of Papillary Thyroid Carcinomas.

Authors:  Husniye Baser; Oya Topaloglu; Abbas Ali Tam; Afra Alkan; Aydan Kilicarslan; Reyhan Ersoy; Bekir Cakir
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

Review 6.  Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management.

Authors:  Emad A Rakha; Sunil Badve; Vincenzo Eusebi; Jorge S Reis-Filho; Stephen B Fox; David J Dabbs; Thomas Decker; Zsolt Hodi; Shu Ichihara; Andrew H S Lee; José Palacios; Andrea L Richardson; Anne Vincent-Salomon; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Ian O Ellis
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

7.  Extremely Well-Differentiated Papillary Thyroid Carcinoma Resembling Adenomatous Hyperplasia Can Metastasize to the Skull: A Case Report.

Authors:  Ju Yeon Pyo; Jisup Kim; Sung Eun Choi; Eunah Shin; Seok Woo Yang; Cheong Soo Park; Seok Mo Kim; Soonwon Hong
Journal:  Yonsei Med J       Date:  2017-01       Impact factor: 2.759

8.  Mutation profiles of follicular thyroid tumors by targeted sequencing.

Authors:  Huanli Duan; Xiaoding Liu; Xinyu Ren; Hui Zhang; Huanwen Wu; Zhiyong Liang
Journal:  Diagn Pathol       Date:  2019-05-10       Impact factor: 2.644

9.  Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.

Authors:  Dalia A Elsers; Mahmoud R A Hussein; Mohammed Hassan Osman; Ghada A Mohamed; Ghada Hosny
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.